pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    Cancer Program
    Metastatic Colorectal Cancer Mirror Biologics Inc
  • Phase 2
    Carboxyamidotriazole Orotate
    Pravitinib
    Glioblastoma Multiforme (GBM) Tactical Therapeutics Inc
  • Phase 2
    CardiALLO
    Systolic Heart Failure (HFrEF)$BCDA BioCardia, Inc.
  • Phase 2
← prev
page 10 of 50
next →
131
Pain89
Neurology1
Carfostin
Non-ischemic Cardiomyopathy
Asklepios BioPharmaceutical Inc
  • Phase 2
    CartiLife
    CartiLife
    Articular Cartilage Defect Biosolution Co Ltd
  • Phase 2
    Cellular Immunotherapy for Metastatic Melanoma, Peritoneal Cancer, Fallopian Tube Cancer and Epithelial Ovarian Cancer
    Metastatic Melanoma The Chaim Sheba Medical Center
  • Phase 2
    CybroCell
    Degenerative Disc Disease$FBLG FibroBiologics, Inc.
  • Phase 2
    Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
    Refractory Acute Myeloid Leukemia Cincinnati Children's Hospital Medical Center
  • Phase 2
    D-0120
    Gouty Arthritis (Gout) InventisBio Co Ltd
  • Phase 2
    D2C7-IT
    Glioblastoma Multiforme (GBM) Istari Oncology Inc
  • Phase 2
    D3S-002
    Non-Small Cell Lung Cancer D3 Bio Inc
  • Phase 2
    DB-041
    Hearing Disorders$REGN REGENERON PHARMACEUTICALS, INC.
  • Phase 2
    DB-1310
    Metastatic Breast Cancer Duality Biotherapeutics Inc
  • Phase 2
    DB-1311
    Esophageal Squamous Cell Carcinoma (ESCC)$BNTX BioNTech SE
  • Phase 2
    DB-1324
    Gastrointestinal Tumor Duality Biotherapeutics Inc
  • Phase 2
    DB-1418
    Head And Neck Squamous Cell Carcinoma (HNSC) Avenzo Therapeutics Inc
  • Phase 2
    DB-1419
    Esophageal Squamous Cell Carcinoma (ESCC) Duality Biotherapeutics Inc
  • Phase 2
    DBV-135
    Milk Allergy DBV Technologies SA
  • Phase 2
    DCC-3009
    Gastrointestinal Stromal Tumor (GIST) Deciphera Pharmaceuticals Inc
  • Phase 2
    DD-01
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… D&D Pharmatech Co Ltd
  • Phase 2
    DF-003
    Chronic Kidney Disease (Chronic Renal Failure) Drug Farm Inc
  • Phase 2
    DLQ-01
    Androgenic Alopecia Dermaliq Therapeutics Inc
  • Phase 2
    DMX-101
    Diarrhea DIMERx Inc
  • Phase 2
    DNL-126
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )$DNLI Denali Therapeutics Inc.
  • Phase 2
    DPTX-3186
    Gastric Cancer Dewpoint Therapeutics Inc
  • Phase 2
    DS-01
    DS-01
    Irritable Bowel Syndrome Seed Health Inc
  • Phase 2
    DS-3939
    Solid Tumor Daiichi Sankyo Co Ltd
  • Phase 2
    DS-7011
    Cutaneous Lupus Erythematosus Daiichi Sankyo Co Ltd
  • Phase 2
    DSG3-CAART
    Pemphigus Vulgaris$CABA Cabaletta Bio, Inc.
  • Phase 2
    DSP-107
    Colorectal Cancer KAHR medical Ltd